Intratumoral heterogeneity of malignant gliomas measured in vitro

Int J Radiat Oncol Biol Phys. 1993 Sep 30;27(2):303-8. doi: 10.1016/0360-3016(93)90241-m.

Abstract

Purpose: To evaluate the extent of intratumoral heterogeneity of radiation sensitivity in malignant gliomas, by comparing the intrinsic radiation sensitivity of different glioma sublines derived from the same tumor.

Methods and materials: The study was performed on five early established malignant gliomas (passage 3-10). Each specimen was quickly cut into three equal pieces (except for one specimen, where only two pieces were obtained). Each piece was processed independently, disintegrated into single cell suspension using a cocktail of enzymes. Survival curve assays, using colony formation as an end-point, were performed for each subline. Comparison between the intrinsic radiation sensitivity of sublines was calculated using the surviving fraction at 2 Gy and the mean inactivation dose as the measured parameters. The DNA content of the cell lines as well as their cell cycle analysis was determined using flow cytometry.

Results: The mean calculated surviving fraction at 2 Gy of all the sublines was 0.37 +/- 0.14, the mean mean inactivation dose was 1.98 +/- 0.63. The intertumoral coefficient of variation for the calculated surviving fraction at 2 Gy of all cell lines was 38%, while that for intratumoral heterogeneity was 25%. Three of the 5 tumors showed a statistically significant difference in the surviving fraction at 2 Gy and mean inactivation dose values of their sublines (p < 0.05). This difference in radiation sensitivity between sublines of the same tumor was not attributed to a difference either in the ploidy status or in the distribution of cells in the cell cycle.

Conclusion: There is a significant intratumoral heterogeneity of radiation sensitivity in some malignant gliomas. This heterogeneity may limit the predictive power of surviving fraction at 2 Gy or mean inactivation dose, especially when their values are based upon a single measurement/single biopsy. In the meantime, this heterogeneity may be a factor in the discrepancy between unexpectedly sensitive tumor cell lines in vitro and their high clinical radiation resistance.

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Brain Neoplasms / genetics
  • Brain Neoplasms / radiotherapy*
  • Cell Survival
  • DNA, Neoplasm / analysis
  • Flow Cytometry
  • Glioblastoma / genetics
  • Glioblastoma / radiotherapy*
  • Glioma / genetics
  • Glioma / radiotherapy*
  • Humans
  • Tumor Cells, Cultured
  • Tumor Stem Cell Assay

Substances

  • DNA, Neoplasm